Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma.

Br J Cancer · 2006 · PMC2361356 · PMID 16685263

Europe PMC DOI

hedged sentence

0.0050

closest p · 0.1× alpha

0.0050

boldest claim

The sentences

highly significantP <0.005actually significant

χ 2 Wilcoxon analysis indicated a highly significant difference ( P <0.005) of PFS in patients with non-transformed ( N =12) compared with transformed disease ( N =4).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.